Molecular Approaches to Treating Pediatric Leukemias-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Molecular Approaches to Treating Pediatric Leukemias

Published:2019-09-06 Issue: Volume:7 Page:
ISSN:2296-2360
Container-title:Frontiers in Pediatrics
language:
Short-container-title:Front. Pediatr.

Author:

Kuhlen Michaela,Klusmann Jan-Henning,Hoell Jessica I.

Funder

Deutsche Forschungsgemeinschaft

Deutsche Kinderkrebsstiftung

St. Baldrick's Foundation

H2020 European Research Council

Publisher

Frontiers Media SA

Subject

Pediatrics, Perinatology, and Child Health

Reference122 articles.

1. Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000;Moricke;Leukemia,2010

2. Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology group;Hunger;J Clin Oncol,2012

3. Childhood acute lymphoblastic leukemia: progress through collaboration;Pui;J Clin Oncol,2015

4. Dexamethasone vs. prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000;Möricke;Blood,2016

5. Successes and challenges in the treatment of pediatric acute myeloid leukemia: a retrospective analysis of the AML-BFM trials from 1987 to 2012;Rasche;Leukemia.,2018

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolving Horizons in Pediatric Leukemia: Novel Insights, Challenges, and the Journey Ahead;Cureus;2024-08-22

2. The potential role of renin angiotensin system in acute leukemia: a narrative review;Molecular Biology Reports;2024-06-21

3. Nano-fenretinide demonstrates remarkable activity in acute promyeloid leukemia cells;Scientific Reports;2024-06-14

4. Emerging and Future Targeted Therapies for Pediatric Acute Myeloid Leukemia: Targeting the Leukemia Stem Cells;Biomedicines;2023-12-07

5. Caracasine, An ent-kaurane Diterpene with Proapoptotic and Pro-differentiator Activity in Human Leukaemia Cell Lines;Anti-Cancer Agents in Medicinal Chemistry;2023-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3